Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, and distributes various pharmaceutical products. It operates through two segments, Nichi-Iko Group and Sagent Group. The company primarily focuses on the production of generic drugs. It offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin " antagonist, angiotensin " antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products, as well as chemotherapeutic agents. The company also provides treatments for circulatory, digestive, respiratory, nervous system, allergies, and others. It supplies its products to medical institutions, including hospitals, clinics, dispensing pharmacies, etc. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was incorporated in 1947 and is headquartered in Toyama, Japan.
Show more...
CEO
Mr. Yuiichi Tamura
직원
2656
국가
JP
ISIN
JP3687200000
상장
0 Comments
생각을 공유하기
FAQ
오늘 Nichi-Iko Pharmaceutical Co 주가는 얼마인가요?▼
4541.TSE의 현재 가격은 ¥35 JPY이며, 지난 24시간 동안 +0% 상승했습니다. 차트에서 Nichi-Iko Pharmaceutical Co 주가 흐름을 더 자세히 살펴보세요.
Nichi-Iko Pharmaceutical Co의 주식 심볼은 무엇인가요?▼
거래소에 따라 주식 심볼이 다를 수 있습니다. 예를 들어, 거래소에서는 Nichi-Iko Pharmaceutical Co 주식이 4541.TSE 심볼로 거래됩니다.